Panacea Biotec Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Panacea Biotec Limited
Symbol
PANACEABIO
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Not Applicable
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
29-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Notes To Annexure1Explanatory Text Block
The Corporate Governance Report submitted in the previous quarter was placed before Board of Directors in its meeting held on 11.02.2026. There were no commments/observations/advice in the meeting held on 11.02.2026. This report will be placed in subsequent meeting of the Board of Directors and comments/observations, if any, will be mentioned in subsequent report.
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.panaceabiotec.com/en/section/information-repository/annual-return
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.panaceabiotec.com/en/section/information-repository/newspaper-publications
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://media.panaceabiotec.com/policy/2021/Dividend%20Distribution%20Policy.pdf
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.panaceabiotec.com/en/section/information-repository/policy
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://www.panaceabiotec.com/en/section/information-repository/subsidiaries-financial-information
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://www.panaceabiotec.com/en/section/information-repository/credit-rating
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.panaceabiotec.com/en/content/about-panacea-biotec
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://media.panaceabiotec.com/policy/2019/Vigil_Mechanism_Policy.pdf
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.panaceabiotec.com/en/section/information-repository/quarterly-results
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://media.panaceabiotec.com/policy/2025/policy-for-determining-material-subsidiaries.pdf
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://media.panaceabiotec.com/policy/2025/policy-on-materiality-of-rpt-and-on-dealing-with-rpt.pdf
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.panaceabiotec.com/en/section/information-repository/shareholding-pattern
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://www.panaceabiotec.com/en/content/disclosures-under-regulation-46-of-sebi
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://www.panaceabiotec.com/en/content/disclosures-under-regulation-46-of-sebi
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://media.panaceabiotec.com/other-important-information/2025/Investorscontact.pdf
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.panaceabiotec.com/en/section/information-repository/corporate-announcement
Disclosure Web Link Of Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021Is Placed
https://media.panaceabiotec.com/policy/2020/panacea-biotec-limited-employee-stock-option-plan-2020.pdf
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://media.panaceabiotec.com/other-important-information/2022/Memorandum%20and%20Articles%20of%20association.pdf
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
https://www.panaceabiotec.com/en/section/information-repository/corporate-presentation
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://www.panaceabiotec.com/en/section/information-repository/secretarial-compliance-report
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Yes
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE922B01023
Market Capitalisation As Per Immediate Previous Financial Year
Top 2000 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Ankit Jain
Name Of Signatory Affirmations
Ankit Jain
Name Of Signatory For Annual Affirmations
Ankit Jain
Name Of Signatory For Quartely Affirmations
Ankit Jain
Name Of The Company
Panacea Biotec Limited
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
New Delhi
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
No - Save and except the loans (or other form of debt) covered under the exclusions provided in SEBI Circular No. SEBI/HO/CFD/CMD-2/P/CIR/2021/567 dated May 31, 2021, the Company has not given any loan (or other form of debt), guarantee / comfort letter (by whatever name called) or provided security in connection with any loan or any other form of debt. Hence, the additional half yearly disclosure is not applicable on the Company.
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
p00021
Scrip Code
531349
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
PANACEABIO
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Yes
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit7
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit8
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

Disclosure Of Notes On Composition Of Board Of Directors Explanatory Text Block
Note: Pursuant to Regulation 26 of the SEBI LODR Regulations, Chairmanship in Committees of all listed entities and Membership in Committees of all public limited companies, whether listed or not, is taken into consideration and all other companies including private limited companies, foreign companies, high value debt listed entities and companies under Section 8 of the Companies Act, 2013 have been excluded.
The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
Yes
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionInitial AppointmentRe-appointmentCessationTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrRajesh Jain******00013053Executive DirectorChairpersonMD26-Apr-1964NoActiveNot Applicable15-Nov-198401-Jan-20251000
2MrSandeep Jain******00012973Executive DirectorNot Applicable17-Jul-1966NoActiveNot Applicable15-Nov-198401-Apr-20251010
3MrAnkesh Jain******03556647Executive DirectorNot Applicable08-Jun-1988NoActiveNot Applicable01-Apr-201601-Apr-20251010
4MrHarshet Jain******08732974Executive DirectorNot Applicable26-Aug-1992NoActiveNot Applicable14-Feb-202514-Feb-20251000
5MrSanjay Trehan******10936402Executive DirectorNot Applicable24-Feb-1959NoActiveNot Applicable14-Feb-202514-Feb-20251010
6MrMukul Gupta******00254597Non-Executive - Independent DirectorNot Applicable16-Aug-1957NoActiveNot Applicable01-Apr-201601-Apr-202131-Mar-20261201111
7MrsAmbika Sharma******08201798Non-Executive - Independent DirectorNot Applicable16-Jun-1962NoActiveNot Applicable14-Feb-202414-Feb-202425.1866102
8MrRajesh Jain******10619014Non-Executive - Independent DirectorNot Applicable13-Feb-1955NoActiveNot Applicable13-Nov-202413-Nov-202416.193373
9MrKrishan Kumar Jalan******01767702Non-Executive - Independent DirectorNot Applicable06-Jun-1957NoActiveNot Applicable14-Feb-202514-Feb-202513.185583
10MrRajender Pal Singh******10198810Non-Executive - Independent DirectorNot Applicable25-Mar-1963NoActiveNot Applicable14-Feb-202514-Feb-202513.182200
11MrVenkatesh Sarvasiddhi******09326552Non-Executive - Independent DirectorNot Applicable25-Sep-1980NoActiveNot Applicable14-Feb-202514-Feb-202513.181100

Committee Disclosures

Entry CompComit100
Date of Appointment
31-Mar-2026
Entry CompComit101
Date of Appointment
31-Mar-2026
Entry CompComit14
Date of Appointment
01-Apr-2024
Date Of Cessation Of Director In Committee
31-Mar-2026
Entry CompComit15
Date of Appointment
14-Nov-2024
Entry CompComit16
Date of Appointment
01-Apr-2024
Entry CompComit17
Date of Appointment
31-Mar-2026
Entry CompComit41
Date of Appointment
29-Mar-2025
Entry CompComit42
Date of Appointment
01-Apr-2024
Date Of Cessation Of Director In Committee
31-Mar-2026
Entry CompComit43
Date of Appointment
14-Nov-2024
Entry CompComit44
Date of Appointment
31-Mar-2026
Entry CompComit68
Date of Appointment
29-Mar-2025
Entry CompComit69
Date of Appointment
29-Mar-2025
Entry CompComit70
Date of Appointment
31-Oct-2014
Entry CompComit95
Date of Appointment
23-Jul-2021
Entry CompComit96
Date of Appointment
23-Jul-2021
Entry CompComit97
Date of Appointment
01-Apr-2024
Entry CompComit98
Date of Appointment
01-Apr-2024
Date Of Cessation Of Director In Committee
31-Mar-2026
Entry CompComit99
Date of Appointment
29-Mar-2025
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Of Notes On Composition Of Committees Explanatory Text Block
Note: 1. Audit Committee, Nomination & Remuneration Committee and Risk Management Committee have been reconstituted w.e.f. 31.03.2026. CA Rajesh Jain has been appointed as Chairman of the Audit Committee w.e.f. 31.03.2026. 2. The Committees which are mandatory under the SEBI LODR Regulations, 2015 and Companies Act, 2013, have only been considered for reporting under this Section. Accordingly, the details of other committees viz. Global Expansion Project Management Committee, Dubai Advance Settlement Committee and ERP System Assessment Committee have not been included.
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.panaceabiotec.com/en/content/about-panacea-biotec/board-committees
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
00254597
Member Name
Mukul Gupta
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Chairperson
Director DIN
10619014
Member Name
Rajesh Jain
Notes
Audit Committee has been reconstituted w.e.f. 31.03.2026. CA Rajesh Jain has been appointed as Chairman of the Audit Committee w.e.f. 31.03.2026
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
08201798
Member Name
Ambika Sharma
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
01767702
Member Name
Krishan Kumar Jalan
Position
Non-Executive - Independent Director

Audit Committee

Audit Committee

Audit Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
08201798
Member Name
Ambika Sharma
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00254597
Member Name
Mukul Gupta
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
10619014
Member Name
Rajesh Jain
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
10198810
Member Name
Rajender Pal Singh
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Nomination and remuneration committee

Risk Management Committee

Additional Position
Member
Director DIN
10619014
Member Name
Rajesh Jain
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
10198810
Member Name
Rajender Pal Singh
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Chairperson
Director DIN
00013053
Member Name
Rajesh Jain
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00012973
Member Name
Sandeep Jain
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
03556647
Member Name
Ankesh Jain
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00254597
Member Name
Mukul Gupta
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
10936402
Member Name
Sanjay Trehan
Position
Executive Director

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
08201798
Member Name
Ambika Sharma
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
10936402
Member Name
Sanjay Trehan
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00012973
Member Name
Sandeep Jain
Position
Executive Director

Stakeholders Relationship Committee

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
14-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
10
Number Of Independent Directors Attending The Meeting
6
Total Number Of Directors As On Date Of The Meeting
11
Entry MeetingBOD2
Dates Of Meeting In The Previous Quarter
15-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
30
Number Of Directors Present In Meeting Of Board Of Directors
10
Number Of Independent Directors Attending The Meeting
6
Total Number Of Directors As On Date Of The Meeting
11
Entry MeetingBOD3
Dates Of Meeting If Any In The Relevant Quarter
11-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
57
Number Of Directors Present In Meeting Of Board Of Directors
11
Number Of Independent Directors Attending The Meeting
6
Total Number Of Directors As On Date Of The Meeting
11
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
14-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Previous Quarter
15-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
30
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
57
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Previous Quarter
13-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Previous Quarter
15-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
31
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Previous Quarter
13-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit7
Dates Of Meeting Of The Committee In The Relevant Quarter
10-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
88
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit8
Dates Of Meeting Of The Committee In The Previous Quarter
13-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
0
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
5
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://media.panaceabiotec.com/other-important-information/2025/Investorscontact.pdf
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://media.panaceabiotec.com/other-important-information/2025/Investorscontact.pdf
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
0
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
0
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Yes
Reason For Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Not Applicable To The Entity
No shares or voting rights of an unlisted company has been acquired by the Company during the quarter ended March 31, 2026, in terms of sub-para 1 of Para A of Part A of Schedule III of SEBI LODR Regulations, 2015
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
No
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
The matter is pending before Hon'ble Supreme Court. No change during the quarter.
Date of Initiation
08-Feb-2012
Opposing Party
Union of India represented through Commissioner of Central GST, Delhi East
Status (Previous Disclosure)
Show Cause Notice (SCN) dated 08-02-2012 for ₹12.94 million was issued by Commissioner of Central Excise Chandigarh alleging availment of ineligible CENVAT Credit. The Company filed a Writ Petition for quashing of SCN. Hon’ble High Court of Punjab and Haryana allowed Writ Petition vide Order dated 26-11-2019 and quashed the SCN. Union of India represented through Commissioner of Central GST, Delhi East preferred Special Leave Petition (SLP) before Hon’ble Supreme Court of India on 22-12-2020 against the High Court’s Order.
Entry I_OngoingTaxLitigationsOrDisputes10
Current Status
The Hon'ble High Court has passed an interim stay order stating inter-alia that no coercive action be taken against the Company in case of final assessment order is passed or a demand is raised. In the meantime, Joint Commissioner, CGST Sub-Commissionerate Mohali, Chandigarh has issued a Demand Order dated 30-03-2026 raising demand aggregating to ~₹228.80 million (towards alleged non-payment of GST of ~₹114.40 million and penalty of ~₹114.40 million). The Company is taking the necessary steps as may be considered appropriate.
Date of Initiation
26-Sep-2025
Opposing Party
Office of the Commissioner, Central GST (Audit) Commissionerate, Punjab
Status (Previous Disclosure)
Show cause notice (SCN) was issued under the Central Goods and Services Tax Act, 2017 (CGST Act) regarding alleged non-payment of GST of ₹114.40 million on providing Corporate Guarantee amounting to ₹8,640 million to Debenture Trustee viz. Vistra ITCL (India) Limited in relation to transfer of pharmaceutical formulations business to the Company’s wholly owned subsidiary viz. Panacea Biotec Pharma Limited, for 1,074 days from 06-04-2019 to 15-03-2022. The Company filed writ petition before the Hon’ble Punjab & Haryana High Court on 24-11-2025, challenging the said Order.
Entry I_OngoingTaxLitigationsOrDisputes11
Current Status
The Company filed appeals with Commissioner of Income Tax (Appeals) ("CIT(A)") against the said Demand Order. The CIT(A) has dismissed the appeals vide its order dated 25-03-2026. The Company is taking necessary steps including filing an appeal with appellate authority against the said Order of the CIT(A).
Date of Initiation
24-Dec-2025
Opposing Party
Assistant Commissioner of Income Tax, New Delhi
Status (Previous Disclosure)
Demand aggregating to ₹93.88 million was raised by Income Tax department vide its three Demand Orders dated 24-12-2025, imposing penalty on account of alleged under reporting of income.
Entry I_OngoingTaxLitigationsOrDisputes12
Current Status
DCIT issued a rectified Assessment Order dated 06-04-2026 wherein the said errors have been corrected, and the Company’s tax liability for AY 2015-16 has been determined as Nil. Accordingly, the matter is now closed.
Date of Initiation
27-Feb-2026
Opposing Party
Deputy Commissioner of Income Tax, New Delhi
Status (Previous Disclosure)
Demand of ₹457.14 million (including interest) was raised by Deputy Commissioner of Income Tax, New Delhi ("DCIT") vide its Demand Order dated 27-02-2026, on account of additions made in the Assessment Order for Assessment Year 2015-16. The Company has noticed errors specifically relating to double addition of disallowances and the omission of set-off for brought-forward losses. Accordingly, the Company has filed a rectification application on 12-03-2026 under Income Tax Act, 1961 (“Act”) to correct such errors.
Entry I_OngoingTaxLitigationsOrDisputes13
Current Status
DCIT issued a rectified Assessment Order dated 06-04-2026 wherein the said errors have been corrected, and the Company’s tax liability for AY 2016-17 has been determined as Nil. Accordingly, the matter is now closed.
Date of Initiation
01-Mar-2026
Opposing Party
Deputy Commissioner of Income Tax, New Delhi
Status (Previous Disclosure)
Demand of ₹102.39 million (including interest) was raised by Deputy Commissioner of Income Tax, New Delhi ("DCIT") vide its Demand Order dated 01-03-2026, on account of additions made in the Assessment Order for Assessment Year 2016-17. The Company has noticed errors specifically relating to double addition of disallowances and the omission of set-off for brought-forward losses. Accordingly, the Company has filed a rectification application on 12-03-2026 under Income Tax Act, 1961 (“Act”) to correct such errors.
Entry I_OngoingTaxLitigationsOrDisputes2
Current Status
ITAT has vide its Order dated 27-02-2026, dismissed the appeal filed earlier by the Deputy Commissioner of Income Tax, New Delhi ("DCIT") against the orders dated 24-07-2015 of CIT (Appeals) and quashed the assessment orders passed by the Assessing Officer for Assessment Year 2005-06.
Date of Initiation
28-Mar-2012
Opposing Party
Deputy Commissioner of Income Tax, Central Circle-05, New Delhi
Status (Previous Disclosure)
Income tax demand of ₹162.22 million in respect to Assessment Year 2005-06 was raised by the Income Tax Department based on certain grounds related to purchases made by the Company from an overseas vendor. The matter was decided in favour of the Company and the addition of income was deleted by Commissioner of Income Tax (Appeals) ("CIT (Appeals)"). However, the Income Tax Department filed an appeal before Income Tax Appellate Tribunal (ITAT) against the order of CIT (Appeals).
Entry I_OngoingTaxLitigationsOrDisputes3
Current Status
The matter is pending before the Hon'ble Delhi High Court. No change during the quarter.
Date of Initiation
29-Jan-2015
Opposing Party
Commissioner of Central GST, New Delhi
Status (Previous Disclosure)
Demand Order dated 29-01-2015 was issued by the Commissioner of Central Excise, Delhi raising demand of ₹62.50 million with penalty and interest of ₹8.10 million on account of non-payment of service tax u/s 68 on gross value of taxable services. The Company filed an appeal before Customs, Excise & Service Tax Appellate Tribunal, Delhi (“CESTAT”) against the said demand order which was allowed by CESTAT. However, Commissioner of Central GST, New Delhi preferred an appeal before the Hon'ble Delhi High Court (“DHC”) on 30-09-2020 which was rejected vide its order dated 10-09-2024. The said Commissioner then filed a Review Petition on 15-11-2024 before DHC against its order.
Entry I_OngoingTaxLitigationsOrDisputes4
Current Status
ITAT has vide its Order dated 27-02-2026: • dismissed the 7 appeals filed earlier by the Deputy Commissioner of Income Tax, New Delhi ("DCIT") against the orders dated 24-07-2015 of CIT (Appeals) arising out of distinct assessment orders passed earlier by the Assessing Officer / DCIT, New Delhi for Assessment Years 2006-07 to 2012-13, respectively. • allowed 2 appeals filed by the Company against the Orders dated 27-07-2015 of CIT Appeals arising out of Assessment Orders passed earlier by the Assessing Officer / DCIT for Assessment Years 2010-11 & 2011-12 respectively; and • quashed the assessment orders passed by the Assessing Officer for Assessment Years 2006-07 to 2012-13.
Date of Initiation
30-Mar-2015
Opposing Party
Deputy Commissioner of Income Tax, Central Circle-05, New Delhi
Status (Previous Disclosure)
A search operation was conducted by the Income Tax Department in the premises of the Company in January 2012 and hence the Company had re-filed the income tax returns for the Assessment Year 2006-07 to 2012-13. During the year ended March 31, 2015, the Income Tax Department completed the assessment of the said years, disallowed certain expenses on various grounds including purchases made from overseas party, FCCB raised, payment to overseas party and freebies given to doctors and issued demand of ₹3,294.90 million (including interest). The Company preferred appeals before the CIT (Appeals) against the orders of the Income Tax Department. The appeals were decided in favour of the Company and the demand was cancelled. However, CIT (Appeals) has made certain disallowances with respect to Assessment Year 2010-11 and 2011-12 against which the Company has filed appeals before the Income Tax Appellate Tribunal (ITAT). The Income Tax Department also filed appeals before ITAT against the orders of CIT (Appeals).
Entry I_OngoingTaxLitigationsOrDisputes5
Current Status
The appeal before the Hon'ble Delhi High Court is pending at present. No change during the quarter.
Date of Initiation
30-Apr-2021
Opposing Party
Deputy Commissioner of Income Tax, Central Circle-05, New Delhi
Status (Previous Disclosure)
Demand of ₹33.69 million was raised by Income tax department vide its order dated 30-04-2021 on account of disallowance made by transfer pricing officer on purchases from / payment of expenses to, related parties in Assessment Year 2016-17. The Company filed an appeal before ITAT and case was decided in favour of the Company. Department filed an appeal against the ITAT order before the Hon'ble Delhi High Court.
Entry I_OngoingTaxLitigationsOrDisputes6
Current Status
The appeal before ITAT is pending at present. No change during the quarter.
Date of Initiation
10-Oct-2023
Opposing Party
Deputy Commissioner of Income Tax, New Delhi
Status (Previous Disclosure)
Demand of ₹91.6 million was raised by Income Tax department vide its order dated 10-10-2023 on account of disallowance made by assessing officer in Assessment Year 2020-21. The Company filed an appeal before Commissioner of Income Tax (Appeals) ("CIT(Appeals)") which was decided against the Company. The Company filed an appeal with ITAT.
Entry I_OngoingTaxLitigationsOrDisputes7
Current Status
The appeal before the Deputy Commissoner of State Tax is pending. No change during the quarter.
Date of Initiation
22-Feb-2025
Opposing Party
Office of Assistant Commissioner of State Tax, GST, Porur, Tamil Nadu
Status (Previous Disclosure)
Demand of ₹8.81 million was raised by GST Department vide its order dated 22-02-2025 in the name of Company's wholly owned subsidiary, Panacea Biotec Pharma Ltd. ("PBPL"), comprising of GST along with interest and penalty thereon, on account of claiming excess input tax credit in its GST returns for the FY 2020-21. PBPL filed an appeal against the said demand order on 20-05-2025 before the Deputy Commissioner of State Tax, Tamil Nadu.
Entry I_OngoingTaxLitigationsOrDisputes8
Current Status
Order dated 10-03-2026 has been received from Deputy Commissioner of State Tax, Maharashtra reducing total demand from ₹15.82 million to ₹8.15 million. The Company is taking the necessary steps as may be considered appropriate including filing an appeal before the appropriate authority.
Date of Initiation
25-Feb-2025
Opposing Party
Office of the State Tax Officer, Mazgaon, Mumbai, Maharashtra
Status (Previous Disclosure)
Demand of ₹15.82 million was raised by GST Department vide its order dated 25-02-2025 in the name of PBPL, comprising of GST along with interest and penalty thereon, on account of claiming excess input tax credit in its GST return for the FY 2020-21. PBPL filed an appeal against the said demand order on 16-05-2025 before the Deputy Commissioner of State Tax, Maharashtra.
Entry I_OngoingTaxLitigationsOrDisputes9
Current Status
The Hon'ble High Court has issued an interim order dated 25-02-2026 pursuant to which the authority has been directed that pending the hearing and final disposal of the petition, no recovery under the impugned orders shall be adopted against the Company. The matter is pending before the Hon'ble Bombay High Court.
Date of Initiation
10-Jul-2025
Opposing Party
Office of the Assistant Commissioner of State Tax, GST Bhawan, Mazgaon, Mumbai, Maharashtra
Status (Previous Disclosure)
Demand Order dated 10-07-2025 of ₹70.34 million was received from the Assistant Commissioner of State Tax, Mumbai towards balance amount of Goods and Service Tax ("GST") (including interest & penalty thereon) on assignment of leasehold rights in land and building by the Company in Navi Mumbai. The Company filed writ petition before the Hon’ble Bombay High Court, challenging the said Order on 04-09-2025.
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
There is no imposition of fine or penalty during the quarter ended March 31, 2026, in terms of sub-para 20 of para A of Part A of Schedule III of SEBI LODR Regulations, 2015
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No